FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Glasser

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Arteries

Co-author Network

Publications

TOP 3
Stephen P Glasser; Martha K Hovater; George Howard; Mary Cushman; Daniel T Lackland; Virginia J Howard
Primary prophylactic aspirin use and incident stroke: reasons for geographic and racial differences in stroke study.
Katie L Corrick; Gordon Fisher; Gary R Hunter; Stephen P Glasser
Changes in vascular hemodynamics in older women following 16 weeks of combined aerobic and resistance training.
Gordon Fisher; Gary R Hunter; Stephen P Glasser
Associations between arterial elasticity and markers of inflammation in healthy older women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Glasser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stephen P Glasser; Martha K Hovater; George Howard; Mary Cushman; Daniel T Lackland; Virginia J Howard
Primary prophylactic aspirin use and incident stroke: reasons for geographic and racial differences in stroke study.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2013;22(4):500-7.
2013: Katie L Corrick; Gordon Fisher; Gary R Hunter; Stephen P Glasser
Changes in vascular hemodynamics in older women following 16 weeks of combined aerobic and resistance training.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(4):241-6.
2013: Gordon Fisher; Gary R Hunter; Stephen P Glasser
Associations between arterial elasticity and markers of inflammation in healthy older women.
The journals of gerontology. Series A, Biological sciences and medical sciences 2013;68(4):382-8.
2013: Monika Maria Safford; Codrin S Barasch; Stephen P Glasser; David C Goff; Jewell H Halanych; Gaurav Parmar; Ronald J Prineas; Todd M Brown
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.
BMC health services research 2013;13():162.
2013: Emily B Levitan; Stephen P Glasser; Suzanne E Judd; Meredith L Kilgore; Monika M Safford; Elsayed Z Soliman; Paul Muntner
Assessment tools for unrecognized myocardial infarction: a cross-sectional analysis of the REasons for Geographic and Racial Differences in Stroke population.
BMC cardiovascular disorders 2013;13():23.
2012: Tanja S Dudenbostel; Stephen P Glasser
Effects of antihypertensive drugs on arterial stiffness.
Cardiology in review 2012;20(5):259-63.
2012: Emmy K Bell; Liyan Gao; Stephen P Glasser; Orlando M Gutiérrez; Suzanne E Judd; Daniel T Lackland; William McClellan; Monika Safford; David G Warnock; Paul Muntner
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
American journal of hypertension 2012;25(7):789-96.
2012: Stephen P Glasser; Dalane W Kitzman; Tatiana Krasikov; Albert Oberman; Amit Patki; Dc Rao; Richard B Devereux; Donna K Arnett
Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.
American journal of cardiovascular disease 2012;2(4):309-17.
2011: Stephen P Glasser; Suzanne E Judd; Jan Basile; Daniel T Lackland; Jewell H Halanych; Mary Cushman; Ronald J Prineas; Virginia J Howard; George Howard
Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
American journal of hypertension 2011;24(2):194-9.
2011: Stephen P Glasser; James Hung; John Lawrence; Dennis Mangano; Evelyn Obot; Shari Targum; Douglas Throckmorton; James Willard; Albert Defelice; John Girton; Raymond J Lipicky
Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
Cardiology 2011;120(3):174-81.
2011: Mary K Wojczynski; Stephen P Glasser; Paul N Hopkins; Edmond K Kabagambe; Albert Oberman; Jose M Ordovas; Robert J Straka; Michael Y Tsai; Donna K Arnett
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
Lipids in health and disease 2011;10():181.
2010: J Bruce Redmon; Alain G Bertoni; Stephanie Connelly; Patricia A Feeney; Stephen P Glasser; Henry Glick; Frank Greenway; Louise A Hesson; Michael S Lawlor; Maria Montez; Brenda Montgomery
Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.
Diabetes care 2010;33(6):1153-8.
2010: Stephen P Glasser; Virginia G Wadley; Suzanne E Judd; Bhumika Kana; Valerie Prince; Nancy Jenny; Brett Kissela; Monika Maria Safford; Ronald Prineas; George Howard
The association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study.
Clinical cardiology 2010;33(5):280-8.
2010: Raegan W Durant; Leslie A McClure; Jewell H Halanych; Cora E Lewis; Ronald J Prineas; Stephen P Glasser; Monika Maria Safford
Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study.
Ethnicity & disease 2010;20(3):282-9.
2009: Stephen P Glasser; Jan N Basile; Daniel T Lackland
Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?
Hypertension 2009;54(5):954-5.
2009: Edmond K Kabagambe; Jose Ordovas; Michael Y Tsai; Ingrid B Borecki; Paul N Hopkins; Stephen P Glasser; Donna K Arnett
Smoking, inflammatory patterns and postprandial hypertriglyceridemia.
Atherosclerosis 2009;203(2):633-9.
2009: Ugochukwu Ezeugo; Stephen P Glasser
Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases.
Expert opinion on pharmacotherapy 2009;10(3):485-91.
2008: Stephen P Glasser; Mary Cushman; Ronald Prineas; Dawn Kleindorfer; Valerie Prince; Zhiying You; Virginia J Howard; George Howard
Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?
Preventive medicine 2008;47(2):161-6.
2008: Stephen P Glasser; Donna K Arnett
Vascular stiffness and the "chicken-or-the-egg" question.
Hypertension 2008;51(2):177-8.
2007: Stephen P Glasser; Maribel Salas; Elizabeth Delzell
Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
Journal of clinical pharmacology 2007;47(9):1074-86.
2006: Stephen P Glasser; George Howard
Clinical trial design issues: at least 10 things you should look for in clinical trials.
Journal of clinical pharmacology 2006;46(10):1106-15.
2006: Stephen P Glasser
Antihypertensive safety and efficacy and physician and patient satisfaction: results from a phase 4 practice-based clinical experience trial with diltiazem LA.
Advances in therapy 2006;23(2):284-94.
2005: Stephen P Glasser; Theophilus J Gana; Luz G Pascual; Kenneth S Albert
Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
American heart journal 2005;149(2):e1-9.
2003: Elizabeth Grey; Chris W Bratteli; Stephen P Glasser; Cheryl Alinder; Stanley M Finkelstein; Bruce R Lindgren; Jay N Cohn
Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events.
American journal of hypertension 2003;16(4):265-9.
2003: Stephen P Glasser; Joel M Neutel; Theophilus J Gana; Kenneth S Albert
Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
American journal of hypertension 2003;16(1):51-8.
2002: Chris W Bratteli; Stephen P Glasser
Effect of doxazosin on arterial elasticity: functional versus structural changes.
Journal of clinical pharmacology 2002;42(10):1105-8.
2001: A Beltran; GE McVeigh; D Morgan; Stephen P Glasser; Joel M Neutel; M Weber; Stanley M Finkelstein; Jay N Cohn
Arterial compliance abnormalities in isolated systolic hypertension.
American journal of hypertension 2001;14(10):1007-11.
2001: Donna K Arnett; Stephen P Glasser; GE McVeigh; Ronald J Prineas; S Finklestein; R Donahue; Jay N Cohn; Alan R Sinaiko
Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study.
American journal of hypertension 2001;14(3):200-5.
1999: GE McVeigh; Chris W Bratteli; DJ Morgan; C M Alinder; Stephen P Glasser; Stanley M Finkelstein; Jay N Cohn
Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance.
Hypertension 1999;33(6):1392-8.
1998: Stephen P Glasser
The relevance of T-type calcium antagonists: a profile of mibefradil.
Journal of clinical pharmacology 1998;38(8):659-69.
1998: Stephen P Glasser; Donna K Arnett; GE McVeigh; Stanley M Finkelstein; A K Bank; DJ Morgan; Jay N Cohn
The importance of arterial compliance in cardiovascular drug therapy.
Journal of clinical pharmacology 1998;38(3):202-12.
1998: Stephen P Glasser
Hypertension, hypertrophy, hormones, and the heart.
American heart journal 1998;135(2 Pt 2):S16-20.
1997: Stephen P Glasser; Donna K Arnett; GE McVeigh; Stanley M Finkelstein; A J Bank; DJ Morgan; Jay N Cohn
Vascular compliance and cardiovascular disease: a risk factor or a marker?
American journal of hypertension 1997;10(10 Pt 1):1175-89.
1997: Stephen P Glasser; D D Michie; U Thadani; W M Baiker
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
The American journal of cardiology 1997;79(10):1401-5.
1997: Stephen P Glasser; S N Singh; D P Humen
Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group.
Journal of clinical pharmacology 1997;37(1):53-7.
1996: Stephen P Glasser; R DiBianco; B A Effron; F Faas; F W Germino; L E Shane; A H Unger; J E Staggers
The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
The American journal of cardiology 1996;77(1):83-5.
1995: Stephen P Glasser; S Ripa; W T Garland; R Weiss; K Nademanee; S Singh; N Bittar
Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Journal of clinical pharmacology 1995;35(8):780-4.
1995: Stephen P Glasser
Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
The American journal of cardiology 1995;75(13):68E-70E.
1994: N J Mangione; Stephen P Glasser
Phenomenon of nitrate tolerance.
American heart journal 1994;128(1):137-46.
1994: Stephen P Glasser; N Bittar; D G Labreche; B Singh; R Katz; P Schulman
Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
The American journal of cardiology 1994;73(16):1165-8.
1993: Steven G Chrysant; Stephen P Glasser; N Bittar; F E Shahidi; K Danisa; R Ibrahim; L E Watts; R J Garutti; R Ferraresi; R Casareto
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
The American journal of cardiology 1993;72(17):1249-56.
1993: Thomas C Andrews; T Fenton; N Toyosaki; Stephen P Glasser; P M Young; Gail MacCallum; R S Gibson; T L Shook; Peter H Stone
Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)
Circulation 1993;88(1):92-100.
1993: Steven Borzak; T Fenton; Stephen P Glasser; T L Shook; Gail MacCallum; P M Young; Peter H Stone
Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Journal of the American College of Cardiology 1993;21(7):1605-11.
1992: R DiBianco; F W Schoomaker; J B Singh; N A Awan; T Bennett; F L Canosa; D T Kawanishi; V S Bamrah; Stephen P Glasser; W Barry
Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
Clinical cardiology 1992;15(7):519-24.
1991: D Rinde-Hoffman; Stephen P Glasser; Donna K Arnett
Update on nitrate therapy.
Journal of clinical pharmacology 1991;31(8):697-701.
1990: Peter H Stone; R S Gibson; Stephen P Glasser; M A DeWood; John D Parker; D T Kawanishi; M H Crawford; F C Messineo; T L Shook; K Raby
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Circulation 1990;82(6):1962-72.
1989: Stephen P Glasser; N Bittar; V Kinhal; W T Bennett; D K Koehn
The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
Journal of clinical pharmacology 1989;29(11):983-8.
1989: Stephen P Glasser; T W West
Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris.
American heart journal 1989;118(5 Pt 2):1127-8.
1989: Stephen P Glasser; D K Koehn; R Powell
Regression of left ventricular hypertrophy in treated hypertensive patients with dilevalol and metoprolol--a double blind randomized study.
Journal of clinical pharmacology 1989;29(9):791-7.
1989: D K Koehn; Stephen P Glasser
The impact of antianginal drug therapy on asymptomatic myocardial ischemia.
Journal of clinical pharmacology 1989;29(8):722-7.
1989: Stephen P Glasser; D K Koehn
Predictors of left ventricular hypertrophy in patients with essential hypertension.
Clinical cardiology 1989;12(3):129-32.
1989: Stephen P Glasser; S G Chrysant; J Graves; B Rofman; D K Koehn
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
American journal of hypertension 1989;2(3 Pt 1):154-7.
1989: Stephen P Glasser; B Arce-Weston; Pamela Irene Clark
Silent myocardial ischemia: improvement with nisoldipine therapy.
Southern medical journal 1989;82(1):32-4, 46.
1988: Stephen P Glasser; T W West
Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
The American journal of cardiology 1988;62(9):518-22.
1988: M W Weston; Stephen P Glasser; D J Stoner; G H Lyman
Clinical assessment of beta blockade.
Clinical cardiology 1988;11(5):311-6.
1988: Pamela Irene Clark; Stephen P Glasser; G H Lyman; J Krug-Fite; A Root
Relation of results of exercise stress tests in young women to phases of the menstrual cycle.
The American journal of cardiology 1988;61(1):197-9.
1983: Stephen P Glasser; Pamela Irene Clark; A R Laddu
Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias.
The American journal of cardiology 1983;52(8):992-5.